Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).

Details

Serval ID
serval:BIB_7276CBC14AD3
Type
Article: article from journal or magazin.
Collection
Publications
Title
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).
Journal
Journal of Clinical Oncology
Author(s)
Ruhstaller T., Pless M., Dietrich D., Kranzbuehler H., von Moos R., Moosmann P., Montemurro M., Schneider P.M., Rauch D., Gautschi O., Mingrone W., Widmer L., Inauen R., Brauchli P., Hess V.
ISSN
1527-7755 (Electronic)
ISSN-L
0732-183X
Publication state
Published
Issued date
2011
Volume
29
Number
6
Pages
626-631
Language
english
Notes
Publication types: Clinical Trial, Phase I ; Clinical Trial, Phase II ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Keywords
Adenocarcinoma/drug therapy, Adenocarcinoma/radiotherapy, Aged, Antibodies, Monoclonal/administration & dosage, Antibodies, Monoclonal/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Squamous Cell/drug therapy, Carcinoma, Squamous Cell/radiotherapy, Cisplatin/administration & dosage, Cisplatin/adverse effects, Digestive System Surgical Procedures, Esophageal Neoplasms/drug therapy, Esophageal Neoplasms/radiotherapy, Female, Humans, Male, Maximum Tolerated Dose, Middle Aged, Multicenter Studies as Topic, Neoadjuvant Therapy/methods, Taxoids/administration & dosage, Taxoids/adverse effects
Pubmed
Web of science
Create date
25/10/2011 9:39
Last modification date
03/03/2018 18:17
Usage data